Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Panitumumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 35 Colonic Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 11 Neoplasms 10 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Carcinoma, Squamous Cell 4 Breast Neoplasms 4 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma Of Esophagus 3 Triple Negative Breast Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Ovarian Neoplasms 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Exanthema 1 Cone Dystrophy 3 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡